Oncotelic Therapeutics, Inc. SEC filings OTLC
Oncotelic Therapeutics, Inc. has 1,007 filings in SEC EDGAR's recent list, going back to Jul 19, 2005. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 30, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Other events
|
Oct 26, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Other events
|
Oct 13, 2026 | Oct 7, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 4, 2026 | Aug 3, 2026 |
| 4 | Insider transaction | Jul 23, 2026 | Jul 10, 2026 |
| D | Filing | Jul 22, 2026 | — |
| 4 | Insider transaction | Jul 21, 2026 | Jul 10, 2026 |
| 8-K |
Current report
Other events
|
Jul 14, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Jul 14, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 14, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 14, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 14, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 14, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 29, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 15, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale
|
May 5, 2026 | May 1, 2026 |
| 8-K |
Current report
Other events
|
Apr 16, 2026 | Apr 16, 2026 |
| 10-K | Annual report | Apr 15, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 2, 2026 | Mar 31, 2026 |
| NT 10-K | Filing | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 30, 2026 | Mar 24, 2026 |
| 8-K |
Current report
Other events
|
Mar 30, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 29, 2026 | Jan 23, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Jan 26, 2026 | Jan 22, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 7, 2026 | Jan 2, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 6, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 6, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 30, 2025 | Dec 23, 2025 |
| EFFECT | Filing | Dec 23, 2025 | — |
| 424B3 | Prospectus | Dec 23, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 23, 2025 | Dec 22, 2025 |
| CORRESP | Letter to the SEC | Dec 22, 2025 | — |
| S-1/A | Amended registration statement | Dec 22, 2025 | — |
| D | Filing | Dec 11, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 9, 2025 | Dec 4, 2025 |
| S-1 | Registration statement | Nov 21, 2025 | — |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 10-Q | Quarterly report | Nov 17, 2025 | Sep 30, 2025 |
| NT 10-Q | Filing | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Other events
|
Oct 22, 2025 | Oct 21, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 12, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 6, 2025 | Jul 31, 2025 |
| 4 | Insider transaction | Jul 10, 2025 | Jul 8, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 424B3 | Prospectus | Apr 29, 2025 | — |
| EFFECT | Filing | Apr 21, 2025 | — |
| POS AM | Filing | Apr 15, 2025 | — |
| 10-K | Annual report | Apr 15, 2025 | Dec 31, 2024 |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Mar 25, 2025 | Mar 23, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Other events
|
Jan 2, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Nov 26, 2024 | Nov 22, 2024 |
| 10-Q | Quarterly report | Nov 19, 2024 | Sep 30, 2024 |
| NT 10-Q | Filing | Nov 14, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Aug 27, 2024 | Aug 23, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Other events
|
Apr 29, 2024 | Apr 26, 2024 |
| 424B3 | Prospectus | Apr 26, 2024 | — |
| EFFECT | Filing | Apr 22, 2024 | — |
| POS AM | Filing | Apr 18, 2024 | — |
| POS AM | Filing | Apr 12, 2024 | — |
| 10-K | Annual report | Apr 12, 2024 | Dec 31, 2023 |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 2, 2024 | Jan 29, 2024 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 30, 2023 | Oct 24, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 23, 2023 | Aug 21, 2023 |
| 10-Q | Quarterly report | Aug 18, 2023 | Jun 30, 2023 |
| NT 10-Q | Filing | Aug 15, 2023 | Jun 30, 2023 |
| D | Filing | Jul 13, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 13, 2023 | Jul 7, 2023 |
| 4 | Insider transaction | Jun 30, 2023 | Jun 28, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 16, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 14, 2023 |
| 4 | Insider transaction | May 31, 2023 | May 26, 2023 |
| 10-Q | Quarterly report | May 22, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 19, 2023 | May 18, 2023 |
| NT 10-Q | Filing | May 15, 2023 | Mar 31, 2023 |
| 424B3 | Prospectus | May 2, 2023 | — |
| 4 | Insider transaction | May 2, 2023 | May 2, 2023 |
| EFFECT | Filing | Apr 25, 2023 | — |
| POS AM | Filing | Apr 20, 2023 | — |
| 10-K/A | Amended annual report | Apr 20, 2023 | Dec 31, 2022 |
| POS AM | Filing | Apr 17, 2023 | — |
| 10-K | Annual report | Apr 14, 2023 | Dec 31, 2022 |
| NT 10-K | Filing | Apr 3, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 2, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 3, 2023 | Dec 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 20, 2022 | Dec 19, 2022 |
| 4 | Insider transaction | Dec 7, 2022 | Dec 6, 2022 |
| 4 | Insider transaction | Nov 25, 2022 | Nov 22, 2022 |
| 10-Q | Quarterly report | Nov 18, 2022 | Sep 30, 2022 |
| NT 10-Q | Filing | Nov 14, 2022 | Sep 30, 2022 |
| 4 | Insider transaction | Sep 28, 2022 | Sep 26, 2022 |
| 4 | Insider transaction | Aug 29, 2022 | Aug 25, 2022 |
| 10-Q | Quarterly report | Aug 22, 2022 | Jun 30, 2022 |
| NT 10-Q | Filing | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 15, 2022 | Jul 12, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 27, 2022 | Jun 22, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 3, 2022 | May 27, 2022 |
| 10-Q | Quarterly report | May 23, 2022 | Mar 31, 2022 |
| NT 10-Q | Filing | May 16, 2022 | Mar 31, 2022 |
| 424B3 | Prospectus | May 11, 2022 | — |
| EFFECT | Filing | May 6, 2022 | — |
| 8-K |
Current report
Officer or director change
|
May 6, 2022 | May 1, 2022 |
| POS AM | Filing | Apr 26, 2022 | — |
| 10-K | Annual report | Apr 15, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 13, 2022 | Apr 7, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 6, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 4, 2022 | Mar 29, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 1, 2022 | Mar 31, 2022 |
| NT 10-K | Filing | Mar 31, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Other events
|
Feb 17, 2022 | Feb 14, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Feb 15, 2022 | Feb 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 9, 2022 | Feb 7, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Feb 2, 2022 | Jan 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 28, 2022 | Jan 26, 2022 |
| 8-K |
Current report
Auditor change
|
Dec 23, 2021 | Dec 21, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Dec 15, 2021 | Dec 9, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 1, 2021 | Nov 24, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 24, 2021 | Nov 23, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 24, 2021 | Nov 23, 2021 |
| 10-Q | Quarterly report | Nov 22, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2021 | Nov 16, 2021 |
| NT 10-Q | Filing | Nov 15, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 28, 2021 | Oct 25, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 27, 2021 | Sep 21, 2021 |
| 424B3 | Prospectus | Sep 27, 2021 | — |
| EFFECT | Filing | Sep 9, 2021 | — |
| 4 | Insider transaction | Sep 8, 2021 | Sep 3, 2021 |
| 4 | Insider transaction | Sep 8, 2021 | Sep 3, 2021 |
| 4 | Insider transaction | Sep 8, 2021 | Sep 3, 2021 |
| 4 | Insider transaction | Sep 8, 2021 | Sep 3, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2021 | Sep 3, 2021 |
| S-3/A | Filing | Sep 8, 2021 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 3, 2021 | Aug 31, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 26, 2021 | Aug 24, 2021 |
| S-3 | Shelf registration | Aug 20, 2021 | — |
| 10-Q | Quarterly report | Aug 20, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Other events
|
Aug 17, 2021 | Aug 16, 2021 |
| NT 10-Q | Filing | Aug 16, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 5, 2021 | Aug 4, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 20, 2021 | Jul 16, 2021 |
| 4 | Insider transaction | Jul 16, 2021 | Mar 31, 2021 |
| 4 | Insider transaction | Jul 16, 2021 | Mar 31, 2021 |
| 4 | Insider transaction | Jul 16, 2021 | Mar 31, 2021 |
| 4 | Insider transaction | Jul 16, 2021 | Jul 8, 2021 |
| 4 | Insider transaction | Jul 16, 2021 | Jul 8, 2021 |
| 4 | Insider transaction | Jul 16, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Jul 2, 2021 | Jun 28, 2021 |
| 8-K |
Current report
Other events
|
Jun 15, 2021 | Jun 11, 2021 |
| 424B3 | Prospectus | Jun 3, 2021 | — |
| EFFECT | Filing | Jun 2, 2021 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 1, 2021 | May 25, 2021 |
| CORRESP | Letter to the SEC | May 28, 2021 | — |
| UPLOAD | Letter from the SEC | May 27, 2021 | — |
| S-1 | Registration statement | May 24, 2021 | — |
| 10-Q | Quarterly report | May 24, 2021 | Mar 31, 2021 |
| NT 10-Q | Filing | May 17, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 7, 2021 | May 3, 2021 |
| 8-K |
Current report
Other events
|
Apr 21, 2021 | Apr 20, 2021 |
| S-8 | Employee stock plan registration | Apr 19, 2021 | — |
| 10-K | Annual report | Apr 15, 2021 | Dec 31, 2020 |
| NT 10-K | Filing | Apr 1, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Other events
|
Mar 30, 2021 | Mar 30, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 26, 2021 | Mar 22, 2021 |
| 8-K |
Current report
Other events
|
Mar 2, 2021 | Mar 1, 2021 |
| 8-K |
Current report
Other events
|
Feb 18, 2021 | Feb 16, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 2, 2021 | Jan 27, 2021 |
| 8-K |
Current report
Other events
|
Feb 2, 2021 | Jan 25, 2021 |
| 8-K |
Current report
Other events
|
Feb 2, 2021 | Feb 2, 2021 |
| 8-K |
Current report
Other events
|
Feb 1, 2021 | Feb 1, 2021 |
| 8-K |
Current report
Other events
|
Jan 15, 2021 | Jan 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 15, 2020 | Dec 14, 2020 |
| 8-K |
Current report
Other events
|
Dec 3, 2020 | Dec 1, 2020 |
| 4 | Insider transaction | Nov 24, 2020 | Nov 20, 2020 |
| 4 | Insider transaction | Nov 23, 2020 | Nov 19, 2020 |
| 4 | Insider transaction | Nov 23, 2020 | Nov 19, 2020 |
| 10-Q | Quarterly report | Nov 16, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Auditor change
|
Nov 4, 2020 | Nov 1, 2020 |
| 8-K |
Current report
Other events
|
Oct 21, 2020 | Oct 19, 2020 |
| 8-K |
Current report
Other events
|
Sep 30, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Other events
|
Sep 28, 2020 | Sep 28, 2020 |
| 8-K |
Current report
Other events
|
Sep 22, 2020 | Sep 21, 2020 |
| 8-K |
Current report
Other events
|
Aug 24, 2020 | Aug 19, 2020 |
| 8-K |
Current report
Other events
|
Aug 19, 2020 | Aug 18, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Aug 14, 2020 | Aug 10, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OTLC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Aguora Hills, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 908259
- Former names
- MATEON THERAPEUTICS INC (until Mar 26, 2021); OXIGENE INC (until Jun 3, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.